 |
 |
 |
360.695.7500
or
877.695.7500
|
Neurotransmitters and Behavior:
Restorative and Energetic Enhancement
Restorative and Energetic Enhancement
Topic
Dr. Willner presents options for use of frequency specific microcurrent therapies for behavioral and cognitive symptoms presented in the context of evaluation of neurotransmitter “imbalances”. This extensive presentation includes a focused review of the principles of basic and nutritional biochemistry necessary to assess and optimze neurotransmitter and synaptic function in the human brain, including review of intracellular and synaptic communications in the nervous system. Clinical and laboratory evaluation techniques are provided and discussed in terms of appropriate utilization. The antecedents, triggers, and mediators related to identifying risk and options for improving neurotransmitter function are reviewed. Specific transmitters and their purported behavioral impacts to be reviewed include dopamine and the catecholamines (epinephrine and norepinephrine), acetylcholine, serotonin, GABA, and the ATP/adenosine energy signaling system. Specific case presentations will be used to demonstrate the principals of evaluating human behavior in the context of neurotransmitter function and how that can be optimized using a Functional Medicine approach with the inclusion of cases that have responded to protocols using FSM. Cases discussed have been chosen from examples of traditional deficiencies, including different forms of depression, examples of addictions and anxiety disorders, cognitive and other neurodegenerative disorders, but the major focus will be on optimizing healthy function at all ages.
Dr. Willner presents options for use of frequency specific microcurrent therapies for behavioral and cognitive symptoms presented in the context of evaluation of neurotransmitter “imbalances”. This extensive presentation includes a focused review of the principles of basic and nutritional biochemistry necessary to assess and optimze neurotransmitter and synaptic function in the human brain, including review of intracellular and synaptic communications in the nervous system. Clinical and laboratory evaluation techniques are provided and discussed in terms of appropriate utilization. The antecedents, triggers, and mediators related to identifying risk and options for improving neurotransmitter function are reviewed. Specific transmitters and their purported behavioral impacts to be reviewed include dopamine and the catecholamines (epinephrine and norepinephrine), acetylcholine, serotonin, GABA, and the ATP/adenosine energy signaling system. Specific case presentations will be used to demonstrate the principals of evaluating human behavior in the context of neurotransmitter function and how that can be optimized using a Functional Medicine approach with the inclusion of cases that have responded to protocols using FSM. Cases discussed have been chosen from examples of traditional deficiencies, including different forms of depression, examples of addictions and anxiety disorders, cognitive and other neurodegenerative disorders, but the major focus will be on optimizing healthy function at all ages.